Connection

Malik Peiris to Immunoglobulin G

This is a "connection" page, showing publications Malik Peiris has written about Immunoglobulin G.
Connection Strength

0.033
  1. Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018. Euro Surveill. 2019 Nov; 24(48).
    View in: PubMed
    Score: 0.009
  2. Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia. J Infect Public Health. 2018 May - Jun; 11(3):331-338.
    View in: PubMed
    Score: 0.008
  3. Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro. Vaccine. 2007 Jan 08; 25(4):729-40.
    View in: PubMed
    Score: 0.004
  4. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis. 2004 Sep; 10(9):1653-6.
    View in: PubMed
    Score: 0.003
  5. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin Diagn Lab Immunol. 2004 Jul; 11(4):665-8.
    View in: PubMed
    Score: 0.003
  6. Evaluation and validation of an enzyme-linked immunosorbent assay and an immunochromatographic test for serological diagnosis of severe acute respiratory syndrome. Clin Diagn Lab Immunol. 2004 Jul; 11(4):699-703.
    View in: PubMed
    Score: 0.003
  7. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol. 2004 May; 42(5):2306-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.